Multicenter Study
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group
Affiliations
- PMID: 7679828
Item in Clipboard
Multicenter Study
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group
Transplant Proc.
1993 Feb.
No abstract available
Similar articles
-
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.Transplant Proc. 1993 Feb;25(1 Pt 1):679-88. Transplant Proc. 1993. PMID: 7679840 Clinical Trial.
-
Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group.Transplant Proc. 1995 Feb;27(1):45-9. Transplant Proc. 1995. PMID: 7533415 Clinical Trial. No abstract available.
-
Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.Transplant Proc. 1996 Apr;28(2):1008-10. Transplant Proc. 1996. PMID: 8623211 Clinical Trial. No abstract available.
-
Clinical use of FK 506 in liver transplantation.Transplant Proc. 1996 Apr;28(2):974-6. Transplant Proc. 1996. PMID: 8623484 Review.
-
Neoral is superior to FK 506 in liver transplantation.Transplant Proc. 1998 Aug;30(5):1812-5. doi: 10.1016/s0041-1345(98)00442-4. Transplant Proc. 1998. PMID: 9723293 Review. No abstract available.
Cited by
-
A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: intermediate-term results.J Thorac Cardiovasc Surg. 1996 Apr;111(4):764-72. doi: 10.1016/s0022-5223(96)70336-7. J Thorac Cardiovasc Surg. 1996. PMID: 8614136 Free PMC article. Clinical Trial.
-
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009. Drugs. 1993. PMID: 7506654 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical